October 27, 2023 – Page 3

Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting

Written by Customer Service on October 27, 2023. Posted in Public Companies.

IRVINE, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) — The following is Nymox’s response to an unauthorized shareholder meeting: Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] (the “Company”) warns its shareholders that false and manipulative behavior is involved in attempts to hold an unlawful, unauthorized, and improper “shareholders meeting” that does not have the support of the Company or anyone currently associated with the Company. A shareholder’s meeting requires at least a quorum of duly registered shareholders, and the small group of individuals requesting the meeting represent about 1.6% of the legitimate shares of the Company. Don’t be misled by their improper, unauthorized, and misleading acts. Long before this group brought their highly suspicious claim in a Bahamas court to secure...

Aimfinity Investment Corp. I Announces Fourth Extension of the Deadline for an Initial Business Combination to November 28, 2023

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Wilmington, Delaware, Oct. 27, 2023 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from October 28, 2023 to November 28, 2023, I-Fa Chang, sole member and manager of the sponsor of the Company, has deposited into its trust account (the “Trust Account”) an aggregate of $85,000 (the “Monthly Extension Payment”). Pursuant to the Company’s second amended & restated memorandum and articles of association (“Current Charter”), effectively July 27, 2023, the Company may extend on a monthly basis from July 28, 2023 until April 28, 2024 or such an earlier date as may be determined by its...

NorthEast Community Bancorp, Inc. Reports Results for the Three and Nine Months Ended September 30, 2023

Written by Customer Service on October 27, 2023. Posted in Earnings Releases And Operating Results.

WHITE PLAINS, N.Y., Oct. 27, 2023 (GLOBE NEWSWIRE) — NorthEast Community Bancorp, Inc. (Nasdaq: NECB) (the “Company”), the parent holding company of NorthEast Community Bank (the “Bank”), reported net income of $11.8 million and $34.2 million, or $0.80 and $2.42 per basic and $0.80 and $2.41 per diluted common share, for the three months and nine months ended September 30, 2023, respectively, compared to net income of $7.5 million and $16.6 million, or $0.49 and $1.07 per basic and diluted common share for the three months and nine months ended September 30, 2022, respectively. Kenneth A. Martinek, NorthEast Community Bancorp’s Chairman of the Board and Chief Executive Officer, stated “We are pleased to report another quarter of strong earnings due to the strong performance of our loan portfolio. Despite the continued increases...

Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Written by Customer Service on October 27, 2023. Posted in Public Companies.

LOQTORZI™ (toripalimab-tpzi) LOQTORZI™ (toripalimab-tpzi) carton – LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy for patients with disease progression on or after platinum containing chemotherapy, irrespective of PD-L1 status – – Conference today at 4:30 p.m. Eastern Daylight Time – REDWOOD CITY, Calif. and SHANGHAI, China, Oct. 27, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, NASDAQ: CHRS), and Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences, HKEX: 1877; SSE: 688180) today announced that the U.S. Food and Drug Administration (FDA) approved LOQTORZI™ (toripalimab-tpzi) in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic...

MICROTEST ANNOUNCES RESULTS OF THE OFFER FOR ROODMICROTEC AND DECLARES IT UNCONDITIONAL

Written by Customer Service on October 27, 2023. Posted in Mergers And Acquisitions.

This is a joint press release by RoodMicrotec N.V. (“RoodMicrotec” and, together with its subsidiaries, the “RoodMicrotec Group”) and Microtest S.p.A. (“Microtest”), an entity incorporated under Italian law, controlled by Seven Holding 3 S.à r.l., a wholly owned subsidiary of the private equity fund Xenon Private Equity VII SCA SICAV RAIF, pursuant to the provisions of Article 16 paragraph 1 and 2 and Article 17 paragraph 1 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft, the “Decree”) in connection with the all-cash recommended public offer by Microtest for all the issued and outstanding ordinary shares in the capital of RoodMicrotec (the “Offer). This press release does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer will be made only by means...

Ozop Energy Solutions, Inc. Introducing Ozop ARC Building Management Energy System (BEMS)- Patent Pending

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Warwick, NY, Oct. 27, 2023 (GLOBE NEWSWIRE) — Ozop Energy Solutions, Inc. (OZSC or the “Company”), is pleased to announce it has a US patent application relating to its Controlled Power Supply in Building Management System (BEMS/ Ozop ARCTM). The OZOP Arc is an industry-defining solution that serves as the hub for our innovative lighting control system. To ensure maximum device compatibility, OZOP ARCTM integrates with auxiliary devices through ethernet or I2C, ensuring unmatched system coherence. The system acts as DHCP server, with standard RJ45 ports for network interface, and wireless connectivity options, including Bluetooth and wireless mesh. Our product line also includes Dum-eTM , an analog to digital input device designed to seamlessly integrate 120V light switches into our controls environment. This flexibility allows...

Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain Brokers, Dealers, Banks and other Nominees Pursuant to Rule 2004 of the Federal Rules of Bankruptcy Procedure

Written by Customer Service on October 27, 2023. Posted in Public Companies.

PALO ALTO, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today filed an emergency motion (the “Motion”) for entry of an order compelling the production of books and records from certain brokers, dealers, banks and other nominees pursuant to Rule 2004 of the federal rules of bankruptcy procedure in the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”). Attached to this press release is the court motion filed by Scilex on October 27, 2023. On October 3, 2023, Scilex provided a proposal to parties with short positions (the “Short Sellers”) in shares of Scilex common stock...

Nokia Corporation: Repurchase of own shares on 27.10.2023

Written by Customer Service on October 27, 2023. Posted in Public Companies.

STOCK EXCHANGE RELEASE 27 October 2023 Nokia CorporationStock Exchange Release 27 October 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 27.10.2023 Espoo, Finland – On 27 Oct 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* AQEU 6,607 3.10 CEUX 60,856 3.10 TQEX 6,505 3.10 XHEL 386,032 3.09 Total 460,000 3.09 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is...

Fentura Financial, Inc. Announces Third Quarter 2023 Earnings (unaudited)

Written by Customer Service on October 27, 2023. Posted in Earnings Releases And Operating Results.

Figure 1 Stock Performance Five-Year Total Return Dollars in thousands except per share amounts. Certain items in the prior period financial statements have been reclassified to conform with the September 30, 2023 presentation. FENTON, Mich., Oct. 27, 2023 (GLOBE NEWSWIRE) — Fentura Financial, Inc. (OTCQX: FETM) announces quarterly net income results of $3,775 and $10,845 for the three and nine months ended September 30, 2023. Ronald L. Justice, President and CEO, stated, “September 2023 marked the 125th anniversary of The State Bank. As one of the largest Michigan-based community banks, we are proud to serve our local communities by providing families, small businesses and commercial customers with safe, sound, and expert financial advice and solutions. We are committed to upholding these core operating principles, which...

Weekly Report (October 20-26, 2023) on the Third Tranche of Stellantis Share Buyback Program

Written by Customer Service on October 27, 2023. Posted in Public Companies.

Weekly Report (October 20-26, 2023) on the Third Tranche of Stellantis Share Buyback Program AMSTERDAM, October 27, 2023 – Stellantis N.V. (“Stellantis” or the “Company”) announced today that pursuant to its Third Tranche of the Share Buyback Program announced on September 11, 2023, covering up to €500 million to be executed in the open market during the period between September 11, 2023 and December 11, 2023, it has repurchased the following common shares in the period between October 20 up to and including October 26, 2023: Date Number of Shares Repurchased Average Market Purchase Price in € per share Repurchased Volume in € (excluding fees) Venues 20/10/2023 792 623 €17.7549 €14 072 923 CEUX 20/10/2023 1 674 293 €17.7530 €29 723 663 MILE 20/10/2023 6 856 €17.7236 €121 513 TQEX 23/10/2023 489 123 €17.8379 €8 724 935 CEUX 23/10/2023 1...

Day: October 27, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice